OLIVA, STEFANIA

OLIVA, STEFANIA  

Mostra records
Risultati 1 - 20 di 33 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autore(i) File
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma 2021 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma 2016 Larocca, A.; Bringhen, S.; Petrucci, M.T.; Oliva, S.; Falcone, A.P.; Caravita, T.; Villani, O.; Benevolo, G.; Liberati, A.M.; Morabito, F.; Montefusco, V.; Passera, R.; De Rosa, L.; Omedé, P.; Vincelli, I.D.; Spada, S.; Carella, A.M.; Ponticelli, E.; Derudas, D.; Genuardi, M.; Guglielmelli, T.; Nozzoli, C.; Aghemo, E.; De Paoli, L.; Conticello, C.; Musolino, C.; Offidani, M.; Boccadoro, M.; Sonneveld, P.; Palumbo, A
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 2020 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis 2017 Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P, Catalano L, Evangelista A, Spada S, Campbell P, Ria R, Salvini M, Offidani M, Carella AM, Omedé P, Liberati AM, Troia R, Cafro AM, Malfitano A, Falcone AP, Caravita T, Patriarca F, Nagler A, Spencer A, Hajek R, Palumbo A, Boccadoro M.
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results 2013 Gay F; Magarotto V; Crippa C; Pescosta N; Guglielmelli T; Cavallo F; Pezzatti S; Ferrari S; Liberati AM; Oliva S; Patriarca F; Offidani M; Omedé P; Montefusco V; Petrucci MT; Giuliani N; Passera R; Pietrantuono G; Boccadoro M; Corradini P; Palumbo A.
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? 2021 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.
Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study. 2014 Bringhen S;Petrucci MT;Larocca A;Conticello C;Rossi D;Magarotto V;Musto P;Boccadifuoco L;Offidani M;Omedé P;Gentilini F;Ciccone G;Benevolo G;Genuardi M;Montefusco V;Oliva S;Caravita T;Tacchetti P;Boccadoro M;Sonneveld P;Palumbo A
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino 2019 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: A randomised, multicentre, phase 3 trial 2015 Gay, Francesca; Oliva, Stefania; Petrucci, Maria Teresa; Conticello, Concetta; Catalano, Lucio; Corradini, Paolo; Siniscalchi, Agostina; Magarotto, Valeria; Pour, Luděk; Carella, Angelo; Malfitano, Alessandra; Petrò, Daniela; Evangelista, Andrea; Spada, Stefano; Pescosta, Norbert; Omedè, Paola; Campbell, Philip; Liberati, Anna Marina; Offidani, Massimo; Ria, Roberto; Pulini, Stefano; Patriarca, Francesca; Hajek, Roman; Spencer, Andrew; Boccadoro, Mario; Palumbo, Antonio
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma 2020 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents 2020 Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A.
Clinical features associated with COVID-19 outcome in multiple myeloma: First results from the International Myeloma Society data set 2020 Chari A.; Samur M.K.; Martinez-Lopez J.; Cook G.; Biran N.; Yong K.; Hungria V.; Engelhardt M.; Gay F.; Feria A.G.; Oliva S.; Oostvogels R.; Gozzetti A.; Rosenbaum C.; Kumar S.; Stadtmauer E.A.; Einsele H.; Beksac M.; Weisel K.; Anderson K.C.; Mateos M.-V.; Moreau P.; San-Miguel J.; Munshi N.C.; Avet-Loiseau H.
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma 2021 Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing 2020 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
Evaluation of immunophenotyc and molecular profiles for Minimal residual disease assessment in multiple myelom: correlation with clinical features and outcome 2021 -
From transplant to novel cellular therapies in multiple myeloma: EMN guidelines and future perspectives 2018 Gay, Francesca; Engelhardt, Monika; Terpos, Evangelos; Wäsch, Ralph; Giaccone, Luisa; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Van De Donk, Niels; Oliva, Stefania; Zamagni, Elena; Garderet, Laurent; Straka, Christian; Hajek, Roman; Ludwig, Heinz; Einsele, Herman; Dimopoulos, Meletios; Boccadoro, Mario; Kröger, Nicolaus; Cavo, Michele; Goldschmidt, Hartmut; Bruno, Benedetto*; Sonneveld, Pieter
Functional impact of genomic complexity on the transcriptome of Multiple Myeloma 2021 Ziccheddu, Bachisio; Da Via, Matteo Claudio; Lionetti, Marta; Maeda, Akihiro; Morlupi, Silvia; Dugo, Matteo; Todoerti, Katia; Oliva, Stefania; D'Agostino, Mattia; Corradini, Paolo; Landgren, Ola; Iorio, Francesco; Pettine, Loredana; Pompa, Alessandra; Manzoni, Martina; Baldini, Luca; Neri, Antonino; Maura, Francesco; Bolli, Niccolò
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma 2024 Ziccheddu, Bachisio; Giannotta, Claudia; D'Agostino, Mattia; Bertuglia, Giuseppe; Saraci, Elona; Oliva, Stefania; Genuardi, Elisa; Papadimitriou, Marios; Diamond, Benjamin; Corradini, Paolo; Coffey, David; Landgren, Ola; Bolli, Niccolò; Bruno, Benedetto; Boccadoro, Mario; Massaia, Massimo; Maura, Francesco; Larocca, Alessandra
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma 2022 Bertamini, Luca; Oliva, Stefania; Rota-Scalabrini, Delia; Paris, Laura; Morè, Sonia; Corradini, Paolo; Ledda, Antonio; Gentile, Massimo; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Curci, Paola; Gilestro, Milena; Capra, Andrea; Galieni, Piero; Pisani, Francesco; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Luppi, Mario; Zambello, Renato; Fazio, Francesca; Belotti, Angelo; Tacchetti, Paola; Musto, Pellegrino; Boccadoro, Mario; Gay, Francesca
High rate of profound clonal and renal responses with daratumumab treatment in heavily pre-treated patients with light chain (AL) amyloidosis and high bone marrow plasma cell infiltrate 2020 Milani P.; Fazio F.; Basset M.; Berno T.; Larocca A.; Foli A.; Riva M.; Benigna F.; Oliva S.; Nuvolone M.; Rodigari L.; Petrucci M.T.; Merlini G.; Palladini G.